Hence, although with a p‐value approaching significance in favour of a higher amount of CLEC12A expressing CD34+CD38− cells in CD34+ AML, in our cohort the level of this particular cell subset is seemingly comparable in MDS and CD34+ AML. This evidence concerns the gene CD38 and acute myeloid leukemia.